1. Home
  2. ARTL vs GV Comparison

ARTL vs GV Comparison

Compare ARTL & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • GV
  • Stock Information
  • Founded
  • ARTL 2011
  • GV 2013
  • Country
  • ARTL United States
  • GV Canada
  • Employees
  • ARTL N/A
  • GV N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • ARTL Health Care
  • GV Real Estate
  • Exchange
  • ARTL Nasdaq
  • GV Nasdaq
  • Market Cap
  • ARTL 6.7M
  • GV 6.8M
  • IPO Year
  • ARTL N/A
  • GV 2022
  • Fundamental
  • Price
  • ARTL $1.80
  • GV $1.37
  • Analyst Decision
  • ARTL Buy
  • GV
  • Analyst Count
  • ARTL 2
  • GV 0
  • Target Price
  • ARTL $30.00
  • GV N/A
  • AVG Volume (30 Days)
  • ARTL 535.2K
  • GV 121.2K
  • Earning Date
  • ARTL 11-12-2025
  • GV 11-25-2025
  • Dividend Yield
  • ARTL N/A
  • GV N/A
  • EPS Growth
  • ARTL N/A
  • GV N/A
  • EPS
  • ARTL N/A
  • GV N/A
  • Revenue
  • ARTL N/A
  • GV $7,773,905.00
  • Revenue This Year
  • ARTL N/A
  • GV N/A
  • Revenue Next Year
  • ARTL N/A
  • GV N/A
  • P/E Ratio
  • ARTL N/A
  • GV N/A
  • Revenue Growth
  • ARTL N/A
  • GV N/A
  • 52 Week Low
  • ARTL $1.66
  • GV $1.02
  • 52 Week High
  • ARTL $28.60
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 23.01
  • GV 35.64
  • Support Level
  • ARTL $1.72
  • GV $1.42
  • Resistance Level
  • ARTL $2.24
  • GV $1.52
  • Average True Range (ATR)
  • ARTL 0.30
  • GV 0.08
  • MACD
  • ARTL -0.03
  • GV -0.01
  • Stochastic Oscillator
  • ARTL 4.10
  • GV 8.66

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: